Steven G. DuBois, MD (he/him/his)

Associate Professor
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Boston, Massachusetts, United States

Dr. DuBois is Director of Experimental Therapeutics at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center. He leads a clinical research team focused on early phase clinical trials, with an emphasis on histology agnostic studies, Ewing sarcoma, and neuroblastoma.

Presentation(s):

• Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR

  Thursday, November 17, 2022
  8:43 AM – 8:51 AM

• Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS

  Thursday, November 17, 2022
  2:08 PM – 2:16 PM

• Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL

  Thursday, November 17, 2022
  2:16 PM – 2:24 PM

• Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP

  Saturday, November 19, 2022
  4:00 PM – 4:08 PM